Zachwieja Nicole J, O'Connell Grant C, Stricker Janelle C, Allen Jessica, Vona-Davis Linda, Bryner Randall, Mandler William, Olfert I Mark
1Division of Exercise Physiology, School of Medicine, West Virginia University, Morgantown, WV; 2Department of Physiology and Pharmacology, School of Medicine, West Virginia University, Morgantown, WV; 3Biomedical Sciences Program, School of Medicine, West Virginia University, Morgantown, WV; 4Department of Surgery, School of Medicine, West Virginia University, Morgantown, WV; 5Mary Babb Randolph Cancer Center, School of Medicine, West Virginia University, Morgantown, WV; and 6Center for Cardiovascular and Respiratory Sciences, School of Medicine, West Virginia University, Morgantown, WV.
Med Sci Sports Exerc. 2015 Nov;47(11):2329-39. doi: 10.1249/MSS.0000000000000663.
Reducing vascular endothelial growth factor (VEGF) in adipose tissue alters adipose vascularity and metabolic homeostasis. We hypothesized that this would also affect metabolic responses during exercise-induced stress and that adipocyte-specific VEGF-deficient (adipoVEGF-/-) mice would have impaired endurance capacity.
Endurance exercise capacity in adipoVEGF-/- (n = 10) and littermate control (n = 11) mice was evaluated every 4 wk between 6 and 24 wk of age using a submaximal endurance run to exhaustion at 20 m·min(-1) at 10° incline. Maximal running speed, using incremental increases in speed at 30-s intervals, was tested at 25 and 37 wk of age.
White and brown adipose tissue capillarity were reduced by 40% in adipoVEGF-/-, and no difference in skeletal muscle capillarity was observed. Endurance run time to exhaustion was 30% lower in adipoVEGF-/- compared with that in controls at all time points (P < 0.001), but no difference in maximal running speed was observed between the groups. After exercise (1 h at 50% maximum running speed), adipoVEGF-/- mice displayed lower circulating insulin (P < 0.001), lower glycerol (P < 0.05), and tendency for lower blood glucose (P = 0.06) compared with controls. There was no evidence of altered oxidative damage or changes in carnitine palmitoyltransferase-1β expression in skeletal muscle of adipoVEGF-/- mice.
These data suggest that VEGF-mediated deficits in adipose tissue blunt the availability of lipid substrates during endurance exercise, which likely reduced endurance performance. Surprisingly, we also found an unchanged basal blood glucose despite lower circulating insulin in adipoVEGF-/- mice, suggesting that loss of adipocyte VEGF can blunt insulin release and/or increase basal insulin sensitivity.
降低脂肪组织中的血管内皮生长因子(VEGF)可改变脂肪组织血管生成和代谢稳态。我们推测这也会影响运动应激期间的代谢反应,并且脂肪细胞特异性VEGF缺陷(adipoVEGF-/-)小鼠的耐力会受损。
在6至24周龄期间,每4周使用次最大耐力跑测试来评估adipoVEGF-/-小鼠(n = 10)和同窝对照小鼠(n = 11)的耐力运动能力,以20米·分钟-1的速度在10°坡度下跑至力竭。在25和37周龄时,以30秒间隔逐渐增加速度的方式测试最大跑步速度。
adipoVEGF-/-小鼠的白色和棕色脂肪组织毛细血管密度降低了40%,而骨骼肌毛细血管密度未观察到差异。在所有时间点,adipoVEGF-/-小鼠的耐力跑至力竭时间比对照组低30%(P < 0.001),但两组之间的最大跑步速度没有差异。运动后(以最大跑步速度的50%运动1小时),与对照组相比,adipoVEGF-/-小鼠的循环胰岛素水平较低(P < 0.001),甘油水平较低(P < 0.05),血糖有降低趋势(P = 0.06)。没有证据表明adipoVEGF-/-小鼠骨骼肌中的氧化损伤改变或肉碱棕榈酰转移酶-1β表达发生变化。
这些数据表明,脂肪组织中VEGF介导的缺陷会削弱耐力运动期间脂质底物的可用性,这可能会降低耐力表现。令人惊讶的是,我们还发现尽管adipoVEGF-/-小鼠的循环胰岛素水平较低,但其基础血糖水平并未改变,这表明脂肪细胞VEGF的缺失会削弱胰岛素释放和/或增加基础胰岛素敏感性。